Loss of the coxsackie and adenovirus receptor (CAR) has been found in various human cancers. Underlying mechanisms, however, are still poorly understood. Therefore, the objective of this study was to investigate the function of hypoxia, a ubiquitous phenomenon in carcinomas, in CAR regulation. In our approach, hypoxia and treatment with cobalt-(II)-chloride (CoCl 2 ) induced a downregulation of CAR protein and mRNA expression, as well as a suppression of CAR gene promoter activity in AGS (gastric), SW480 (colon) and PC3 (prostate) cancer cells. In line with these findings we noted a decreased adenoviral uptake under hypoxic conditions. Aiming to further elucidate the molecular basis of this observation, a full-length hypoxia-inducible factor-1a (HIF-1a) cDNA was ectopically overexpressed in the AGS cell line diminishing CAR expression and CAR gene promoter activity. In line with these findings, exposure of HIF-1a-deficient AGS cells to hypoxia did not alter CAR mRNA expression level. On the basis of these data, it may be suggested that loss of CAR in human cancer cell lines under hypoxic conditions occurs in an HIF-1a-dependent manner.
Introduction
Coxsackie and adenovirus receptor (CAR), a transmembrane glycoprotein, was initially characterized as a viral attachment site on the cell surface. 1 Further scientific study identified CAR as component of the tight junctions (TJs), interacting partner for other TJ proteins and regulator of TJ formation. [2] [3] [4] [5] [6] [7] In the context of cancer, data from in vitro and in vivo assays suggest that CAR regulates intercellular adhesion, suppresses proliferation, inhibits migration and invasion of cancer cells. [8] [9] [10] [11] [12] [13] In line with these findings, reduced CAR expression has been documented particularly in advanced cancers of bladder, prostate, esophagus, stomach, pancreas, liver and colon. [14] [15] [16] [17] [18] [19] In addition to the potential tumor-biological implications of reduced CAR expression in carcinomas, it also poses a crucial obstacle for novel strategies in cancer therapy that require CAR as binding site for attenuated adenoviruses. 20 Previously it has been suggested that loss of CAR in malignant disorders may be caused by an activation of the Raf/MEK/ERK pathway, the transforming growth factor-b signaling cascade, epithelial-mesenchymal transdifferentiation and histone deacetylation of the CAR gene promoter. 8, [21] [22] [23] In contrast, the potential function of hypoxia in the regulation of CAR expression has not yet been investigated. Hypoxia marks a crucial feature of advanced carcinomas and has been linked to malignant progression, increased rates of recurrence, locoregional spread and distant metastasis. 24 A series of hypoxiainduced proteomic and genomic changes have been suggested to mediate the effect of hypoxia on tumor progression, with the transcription factor hypoxiainducible factor-1a (HIF-1a) representing a central regulator of tumor cell adaptation to hypoxic conditions. 24 However, the effect of hypoxia on TJs in cancers is poorly understood. Previously, hypoxia has been found to induce the transcription factors Snail and Slug. 25 Ectopic expression of Snail or Slug in an ovarian cancer cell line led to epithelial-mesenchymal transdifferentiation and downregulation of the TJ proteins, occludin and ZO-1. 25 These findings suggest a suppression of TJ formation by hypoxia in malignant tumors. Intrigued by these observations, we aimed to investigate the effect of hypoxia on CAR expression in human cancer cells to elucidate the regulatory mechanisms of CAR in cancers, which may affect tumor biology and adenovirus-based therapeutic approaches. 
Materials and methods

Cell
Assessment of infectivity with adenovirus
A non-replicating, human adenovirus type 5 (dE1/E3) expressing green fluorescent protein (GFP) (Vector Biolabs, Philadelphia, PA) was used to measure the infectivity of cells. Infections were carried out after treatment with CoCl 2 for 48 h. Cells were washed and then incubated in infection medium containing 2% FBS and adenovirus at a concentration suitable to achieve a multiplicity of infection of 10. After 24 h, maintaining treatment with CoCl 2 , GFP expression was documented using a Zeiss Axiophot microscope (Carl Zeiss AG, Jena, Germany) and determined by fluorescence-activated cell sorting analysis.
Ectopic expression and functional knockdown of HIF-1a
Functional inactivation of HIF-1a in AGS gastric cancer cells was achieved by means of a lentivirus-based siRNA approach as previously described. 26 Loss of HIF-1a was confirmed by western blot analysis for HIF-1a and HIF-1a target genes, and an hypoxia-responsive element luciferase reporter assay. 26 
Western blotting
Total protein lysates were obtained as previously described. 21 For western blotting equal amounts of protein lysates were loaded on reducing Laemmli gels, immunoblotted with specific antibodies against CAR (H-300: sc-15405, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, 1:200) or b-actin (Sigma-Aldrich, 1:1000), and signals were detected using the ECL system (Amersham Pharmacia, Piscataway, NJ). Protein lysates of CHO and CHO-CAR cells were used as negative and positive controls, respectively.
Quantitative mRNA determination Total RNA was isolated using TRIZOL (Invitrogen, Karlsruhe, Germany) and reversely transcribed with Oligo-dT primers and SuperScript II (Invitrogen). cDNAs generated from 1 mg of total RNA were used for real-time quantification using CAR gene-specific primers as previously described 27 and the TaqMan Universal Master Mix (Applied Biosystems, Foster City, CA). Snail and Slug expression was assessed using gene-specific primers as previously described 25 using the Power SYBR Green Master Mix (Applied Biosystems, Darmstadt, Germany). Following real-time (RT)-PCR on a Stratagene MX3000P cycler (La Jolla, CA), quantification was performed by the comparative DC T method normalizing C T -values to b-Actin.
Assessment of CAR gene promoter activity CAR gene promoter activity was determined in a reporter gene assay. In brief, cells were cotransfected with either a CAR gene promoter construct: 'pGL3-186' (a kind gift of Dr RC Pong and Dr JT Hsieh, Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX) or the control vector 'pGL3-basic' (Promega Corporation, Madison, WI), and Renilla-Luciferase using Effectene (Qiagen GmbH, Hilden, Germany) according to the manufacturer's protocol. At 4 h after transfection, fresh serum-free cell culture media were added and cells were subjected to hypoxia or CoCl 2 treatment for 24 h. Luciferase activity was determined using the DualLuciferase Reporter 1000 Assay System (Promega Corporation, Madison, WI) using a Microplate Luminometer LB 96 V (EG & G Berthold, Bad Wildbad, Germany).
Statistical analysis
Statistical calculations were carried out using t-test (GraphPad Prism software, version 4.00; GraphPad Software, Inc., San Diego, CA).
Results
Hypoxia and CoCl 2 reduce CAR expression and CAR gene promoter activity in cancer cell lines The influence of hypoxia on CAR expression was determined in the human cancer cell lines AGS, SW480, and PC3 following cultivation under hypoxic conditions or after treatment with the hypoxia-mimicking agent CoCl 2 , respectively, for up to 48 h. Either condition caused a downregulation of CAR protein expression in all tested cell lines compared with normoxic conditions (20% O 2 ) (Figure 1a) . To assess whether the loss of CAR expression results from transcriptional regulation, CARspecific quantitative RT-PCRs and reporter gene assays were carried out. These experiments showed a downregulation for both CAR mRNA expression and CAR gene promoter activity in all three cell lines under hypoxia in comparison with normoxia (Figure 1b) . To assess whether the reduced CAR expression affects the virus uptake, all cell lines were infected during treatment with CoCl 2 with a non-replicating adenovirus expressing GFP.
These experiments showed a significantly reduced viral transduction in AGS and SW480 cells in comparison with matching control cells cultured under normoxia. In contrast, no differences in GFP expression were observed in the PC3 cell line. However, even cells under normoxia displayed a very low infection rate, with only 2% of the cells being GFP positive (Figure 1c) .
Downregulation of CAR depends on the presence of HIF-1a
As the transcription factor HIF-1a has been identified as a key regulator of the cellular response to hypoxia, we investigated the effect of HIF-1a expression on CAR mRNA expression and CAR gene promoter activity in the AGS cell line. After transfection of a full-length HIF-1a construct, a significant downregulation of CAR mRNA expression was observed. Moreover, cotransfection of the full-length HIF-1a construct and a CAR gene promoter construct showed a significant suppression of CAR gene promoter activity by HIF-1a (Figure 2a) . To further establish the potential function of HIF-1a in CAR regulation, CAR mRNA expression was assessed by an RT-PCR assay in AGS cells after functional knockdown of HIF-1a. These assays showed equal CAR mRNA expression levels in AGS HIF-1a knock down cells subjected to either hypoxia or normoxia, in contrast to the loss of CAR in AGS cells transfected with a scrambled siRNA control under 1% O 2 (Figure 2b) .
Expression of the transcription factors snail and slug under hypoxic conditions
The transcription factors Snail and Slug have previously been shown to be upregulated by hypoxia, and are furthermore implicated in the suppression of the TJ-associated proteins occludin and ZO-1. 25 To test whether these factors may be involved in the regulation of CAR as well, quantitative RT-PCR assays using genespecific primers were carried out. These assays showed a downregulation of Snail in all the tested cell lines under hypoxic conditions compared with normoxia. In contrast, Slug displayed an 8.63-fold increase under hypoxia in the SW480 cell line, whereas a 1.44-fold gain was noted in PC3 cells. No detectable Slug mRNA expression was found in the AGS cell line (Figure 3 ).
Discussion
Here, we report for the first time that hypoxia induces loss of CAR in human cancer cells. Our findings are in contrast to a previous report by Shen et al. 27 showing that hypoxia had no significant effect on CAR in two human colon cancer cell lines. These differences may be explained by distinct methods, as incubation times under hypoxic conditions vary considerably between the study by Shen et al. and the current study. Nevertheless, cell line-specific variations regarding the effects of hypoxia on CAR expression may potentially exist. As our findings are based on cell lines derived from various entities, it may be speculated that the downregulation of CAR under hypoxic conditions represents an entity-independent phenomenon. Our data suggest that these changes are mediated on the transcriptional level as the activity of the CAR gene promoter was markedly reduced under hypoxic conditions. Furthermore, we show a crucial function for the transcription factor HIF-1a in the observed downregulation of CAR under hypoxic conditions, as no change in CAR expression was induced by hypoxia in AGS cells after HIF-1a knockdown. This hypothesis was further substantiated by the fact that transient HIF-1a transfection was sufficient to induce a loss of CAR mRNA expression and CAR gene promoter activity. However, within the 186-bp region of the CAR gene promoter used for these experiments, no consensus sequence for a 'hypoxia-responsive element' (5 0 -(A/G)CGTG-3 0 ) was found. 28 Therefore, it must be speculated that HIF-1a does not bind to the CAR gene promoter directly. Instead, HIF-1a may potentially induce other transcription factors that eventually suppress CAR gene promoter activity.
Previously, hypoxia has been found to induce transcriptional factors Snail and Slug. Ectopic expression of Snail or Slug in ovarian cancer cells (SKOV3) resulted in epithelialmesenchymal transition, paralled by an enhanced motility, invasiveness and tumorigenecity, and reduced expression of the TJ associated proteins occludin and ZO-1. 25 Therefore, we quantified the expression of Snail and Slug under hypoxia using RT-PCR. These assays showed only a marked increase in Slug in the SW480 cell line, whereas Snail displayed reduced expression in all tested cell lines. On the basis of these findings, we conclude that these transcription factors are not involved in the downregulation of CAR by hypoxia in the tested cell lines.
Attenuated adenoviruses, either replication-incompetent viruses delivering therapeutic genes or viruses that replicate restrictedly in cancer cells, are currently under investigation in clinical trials. 29 However, frequent downregulation of CAR in carcinomas, in particular in advanced cancers, has been implicated in the restricted response so far. 30 Our data suggest that hypoxia may result in reduced CAR expression accompanied by restricted virus uptake in cancers. Therefore, it may be speculated that strategies inhibiting hypoxia/HIF-1a in cancers may improve the delivery of adenoviruses. However, as previous studies showed that neither CAR nor virus uptake is affected under hypoxia in other cancer cell lines, our findings may apply to a subset of cancers only. 27, 31 Moreover, considering the variety of pathways that have been linked to the loss of CAR in cancers, 8, [21] [22] [23] our data do also underline the need for modified adenoviruses that bind to the cell surface independently of CAR in novel concept for cancer treatment. 32 Abbreviations CAR, coxsackie and adenovirus receptor; TJ, tight junctions; HIF-1a, hypoxia-inducible factor-1a; FCS, fetal calf serum; GFP, green fluorescent protein . 
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